Skip to main contentSkip to user menuSkip to navigation

Computational Biology Platforms

Design computational biology platforms for genomics, protein folding, and drug discovery with HPC and ML integration.

50 min readAdvanced
Not Started
Loading...

What is a computational biology platform?

A computational biology platform turns biological samples and reference data into traceable scientific results. It combines governed data storage, workflow orchestration, elastic or scheduled compute, standardized file formats, and a durable record of every run.

In plain language, a researcher should be able to submit a cohort, run an analysis, inspect failures, and later prove exactly which inputs, reference sequences, tools, parameters, and permissions produced each output. The platform may use a workstation, an HPC scheduler, a cloud batch service, or several execution backends; the scientific contract must survive all of them.

Core invariant

A published result must be traceable to immutable input content, an unambiguous reference, a reviewed workflow revision, pinned runtime artifacts, explicit parameters, and a durable run record. Faster compute cannot repair missing lineage.

Which sample and reference?

Biological identity

Identify files and reference sequences by verified content, while keeping sample, participant, assay, and consent metadata under appropriate governance.

Which computation?

Workflow contract

Version the workflow graph, tools, runtime images, resources, parameters, and expected outputs independently of the cluster that executes them.

Why this result?

Evidence trail

Record task attempts, input and output digests, logs, timestamps, identities, and policy decisions so a failed or published run can be investigated.

Who may use the data?

Governed execution

Enforce approved purpose, dataset restrictions, least privilege, audit, retention, and egress rules at the data and execution boundaries.

Build one traceable path from sample to result

A platform is not just a collection of bioinformatics tools. It is a control plane that resolves identity and authorization, and a data plane that moves large objects through bounded computations.

A result should retain its full computational lineage

Control metadata stays small and queryable; large biological objects move through governed storage and isolated task workspaces.

1. Resolve identity

Study manifest

Maps approved sample identifiers to immutable object checksums, assay metadata, data-use restrictions, and a checksum-addressed reference assembly.

2. Plan the DAG

Workflow service

Validates the workflow revision and parameter document, expands scatter operations, and creates stable run and task-attempt identities.

3. Run near data

Execution backends

Schedules isolated tasks on eligible HPC or cloud capacity, stages only authorized inputs, pins runtime artifacts, and publishes logs without embedding secrets.

4. Verify and publish

Results and provenance

Validates output checksums and schemas, stores the run manifest, applies retention and access policy, and exposes results through durable object identifiers.

Keep these identities separate:

  • Participant and sample identity describe the biological source and remain subject to consent, privacy, and study policy.
  • Object identity describes file content. A path or filename is a location, not proof that two inputs contain the same bytes.
  • Reference identity describes the exact sequence used by an aligner or caller. A convenient alias such as hg38 is not sufficient when providers can package or name sequences differently.
  • Run identity describes one submitted workflow and its parameters; task-attempt identity distinguishes retries without pretending they are new scientific inputs.

Size a cohort from measured workload inputs

Capacity planning starts with quantities the team can observe: samples, raw GiB per sample, derived-data expansion, retained copies, measured worker-slot hours per sample, usable worker slots, and sustained network throughput. Do not hide these behind a generic "analysis complexity" score.

Lab 1: expose the data and compute envelope

Choose a teaching profile, then adjust cohort size, network throughput, worker slots, and retention. Every output is derived from visible arithmetic. The profile values are planning examples, not claims about a sequencing platform or workflow; replace them with measurements from representative samples before procurement or scheduling.

Loading cohort model

Reading planning assumptions...

Calculate a cohort envelope from explicit measurements

Interpret each budget independently:

  • Retained footprint includes raw and derived objects multiplied by the chosen copy count. It excludes temporary workspace and object-store implementation overhead.
  • Transfer time is the lower-bound time to move the raw bytes at the selected sustained payload rate. Protocol overhead, retries, parallel-source limits, and provider quotas must be measured separately.
  • Compute time divides measured worker-slot hours by effective parallel slots. It is not elapsed-time proof when the DAG has serial stages, skewed samples, queue waits, or scarce high-memory tasks.
  • Workspace peak depends on which tasks overlap. Measure it from task traces rather than multiplying every intermediate by the cohort size forever.

Orchestrate a DAG, not a directory of shell scripts

Scientific pipelines naturally form a directed acyclic graph: independent samples can fan out, cohort-level aggregation creates barriers, and downstream interpretation must wait for validated upstream artifacts.

  1. 1

    Contract

    Validate the submission

    Authorize the dataset and requested purpose. Resolve immutable inputs, reference content, workflow revision, runtime digests, parameters, and output policy before work is admitted.

  2. 2

    Plan

    Expand deterministic tasks

    Create a stable task key from the declared inputs and computation. Record scatter groups, dependencies, resource requests, retry policy, and the expected output contract.

  3. 3

    Run

    Execute with isolation

    Stage authorized data into a task workspace, run without shell interpolation, capture resource use and logs, and publish outputs only after exit status and validation pass.

  4. 4

    Publish

    Commit evidence

    Checksum outputs, write the immutable run manifest, link every attempt, apply access and retention policy, then expose durable result identifiers to researchers.

Retries are operationally safe only when the task contract is idempotent. Write to an attempt-scoped location, validate the complete output set, and atomically publish the winning manifest. Never let two attempts race to mutate the same result directory.

Portable workflow descriptions help separate pipeline logic from execution. The Common Workflow Language describes command-line tools and workflows, while the GA4GH Workflow Execution Service standardizes submission and run monitoring across execution platforms. Neither standard chooses your authorization, provenance retention, validation, or retry semantics.

Make reproducibility a testable evidence contract

"We saved the script" is not enough. A script can read changed input bytes, resolve a different reference behind the same nickname, pull a moved container tag, or use edited parameters. Capture the evidence needed to detect each kind of drift and to replay the run deliberately.

Lab 2: diagnose a broken lineage

Select a failure, then turn evidence controls on or off. The lab does not produce a fuzzy reproducibility score: it reports whether the selected change is detectable and whether the minimum replay envelope is complete.

Loading provenance lab

Reading evidence contracts...

Validate a run manifest before publishing results

Content addressing solves identity, not trust by itself. A digest can prove that bytes match an expected value; it does not prove the dataset was authorized, the tool was reviewed, or the scientific method was appropriate. Keep review, authorization, and signature policy as explicit controls.

For concrete interoperability contracts, review:

Govern data by approved use, not by storage location alone

Human genomic and linked phenotype data can remain sensitive even when direct identifiers are removed. The platform must turn the study's consent and data-use terms into enforceable access, execution, retention, and sharing controls.

Reduce uncontrolled copies

Bring compute to data

Execute approved workflows in a governed environment when possible. Short-lived access credentials and isolated workspaces reduce the need to distribute full datasets.

Limit privilege

Separate control and data

The orchestrator may schedule a task without being able to read every biological object. Issue task-scoped access and deny unrelated datasets, destinations, and network paths.

Prove responsible use

Audit the full lifecycle

Record approvals, access, exports, policy decisions, administrative changes, incidents, retention actions, and verified deletion without placing sensitive payloads in logs.

For NIH controlled-access genomic data, approved users and their institutions are responsible for confidentiality, integrity, security, and adherence to the applicable Data Use Certification.

A cloud or third-party provider does not transfer that institutional responsibility. Read the current NIH guidance on using genomic data responsibly and apply the policy that governs the actual dataset and jurisdiction.

Before a run starts, verify:

  • the principal, project, approved research use, and access period are current;
  • every input and destination is allowed by the dataset's use and residency terms;
  • credentials are short-lived, least-privileged, and absent from parameters and logs;
  • task workspaces, snapshots, caches, logs, and exports have retention and deletion behavior; and
  • an incident path can suspend access, preserve evidence, identify affected objects, and notify the accountable owners.

Operate for scientific recovery, not just job completion

Measure the platform at three layers:

  • Scientific validity: sample-sheet validation, contamination and identity checks, reference compatibility, expected output schemas, and domain-specific quality gates.
  • Execution reliability: queue delay, task duration and variance, retry causes, preemption recovery, cache reuse, failed publication, orphan workspaces, and backend quota pressure.
  • Evidence integrity: missing input or output digests, mutable runtime references, incomplete task logs, unlinked attempts, unauthorized access, and retention-policy failures.

Test failure modes deliberately:

  1. replace an input object behind an unchanged path and require checksum validation to stop the run;
  2. remove a worker during a long scatter stage and verify only incomplete tasks retry;
  3. let two attempts finish together and verify one manifest is published atomically;
  4. make the results store unavailable and prove computed outputs are not reported as published;
  5. revoke dataset access during queued work and ensure the task re-authorizes before staging; and
  6. replay a historical run in a clean environment using only its retained manifest and approved data access.

The operational objective is not "every task succeeds." It is that failures remain bounded, visible, recoverable, and scientifically explainable.

No quiz questions available
Could not load questions file
Spotted an issue or have a better explanation? This page is open source.Edit on GitHub·Suggest an improvement